Topical Calcipotriol Versus Narrowband Ultraviolet B in Treatment of Alopecia Areata
Launched by ASWAN UNIVERSITY HOSPITAL · Feb 18, 2019
Trial Information
Current as of May 03, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Alopecia Areata of scalp
- Exclusion Criteria:
- • Other causes of alopecias including scarring alopecia, androgenic alopecia, telogen effluvium autoimmune diseases, pregnant and lactating females
About Aswan University Hospital
Aswan University Hospital is a leading medical institution in Egypt dedicated to advancing healthcare through innovative research and clinical trials. Affiliated with Aswan University, the hospital provides a multidisciplinary approach to patient care, integrating education, research, and clinical practice. With state-of-the-art facilities and a commitment to ethical standards, Aswan University Hospital aims to enhance medical knowledge and improve patient outcomes by actively participating in clinical trials across various therapeutic areas. The institution fosters collaboration among healthcare professionals, researchers, and academic partners to drive scientific discovery and contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aswan, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials